1. Inside the dragon: Outsourcing destinations in China
05-24-2010
China has become an emerging location amid the development of the global outsourcing sector, and establishing a physical presence in China is now a necessary strategy for outsourcing enterprises. A wide range of enterprises have set up service outsourcing operation bases in various Chinese cities, including global outsourcing enterprises and relatively new domestic Chinese enterprises.
2. Biomics to co-develop a Hepatitis B RNAi therapeutic with Benitec
07-20-2009
Biomics Biotechnologies Co. Ltd. has signed collaboration MOU with Benitec Ltd., to co-develop a Hepatitis B RNAi therapeutics.
3. The bioeconomy is key to tackling many future global challenges
06-08-2009
The biological sciences are adding value to a host of products and services, producing what some have labelled the “bioeconomy”. From a broad economic perspective, the bioeconomy refers to the set of economic activities relating to the invention, development, production and use of biological products and processes. If it continues on course, the bioeconomy could make major socioeconomic contributions in OECD and non-OECD countries. These benefits are expected to improve health outcomes, boost the productivity of agriculture and industrial processes, and enhance environmental sustainability. The bioeconomy’s success is not, however, guaranteed: harnessing its potential will require coordinated policy action by governments to reap the benefits of the biotechnology revolution.
4. Private-sector consumer medication information found not consistently useful
12-23-2008
A study released recently by the U.S. Food and Drug Administration found that the printed consumer medication information (CMI) voluntarily provided with new prescriptions by retail pharmacies does not consistently provide easy-to-read, understandable information about the use and risks of medications.
5. Patenting and Innovation in Industrial Biotechnology
11-10-2008
Innovation in industrial biotechnology is strong and growing, and patents are playing a central role, according to a new staff research study by the U.S. International Trade Commission’s (ITC) Office of Industries.
Patenting and Innovation in Industrial Biotechnology uses patent data, survey results, and profiles of firms in two emerging sectors (cellulosic ethanol and bio-based plastics) to paint a new picture of innovation in industrial biotechnology.
6. Opportunities of outsourcing biopharmaceutical R&D to China
09-27-2008
The market for Research and Development (R&D) outsourcing in the biopharmaceutical industry represents a significant economic opportunity for China. The global outsourcing market, though, is highly competitive. In much of the industry literature, China is portrayed to be an increasingly important player in this market, but one that is lagging behind other developing markets, especially India.
This report offers a vision for China that reaches beyond the current models and drivers of outsourcing. This vision moves from the concept of outsourcing to one of strategic sourcing, thus paving the way to successfully competing in an industry where R&D will increasingly be performed by global companies that create nimble, virtual operating groups comprised of the best-in-class talent required for each project. How can the Chinese biopharmaceutical industry establish itself as the preferred partner in this type of competitive marketplace?
This report will address these critical issues, highlighting recommen
7. India and China as partner of choice for the western multi national companies in the era of globalisation
08-19-2008
This paper explores the potential of Indian and Chinese biopharma industries in becoming the best trading partner of western Multinational biopharma companies in the globalised world.
8. Neglected diseases drugs innovation in Indian biopharmaceutical industry: a status Report
10-09-2007
Neglected diseases such as HIV/AIDS, malaria and tuberculosis have a very strong negative impact on poor populations. New drugs are required to tackle the persistent challenge of malaria, TB and HIV etc. The paper highlights the need of such drugs and explores the efforts made towards the innovation of such drugs in India along with some commentary on the adequacy of such efforts.
9. China Life Sciences Summit · Beijing 2007
09-21-2007
The summit is proved to be another important international event of Chinese pharmaceutical industry. Chinese government officials, experts, academics and industry leaders, well-known international pharmaceutical enterprises, VCs invested enterprises and the FDA experts come together, centering on "cooperation and win-win" theme and three simultaneous tracks with six forums.
10. World Cancer Conference
09-15-2007
In 13th September, the World Cancer Conference, co-organized by IBC Conferences and Event Management Services (Shanghai) Ltd. and People's Medical Publishing House, was held at the Westin Beijing. The conference lasted two days.
[1]